Tech transfer teams’ IP challenges post-COVID and beyond: Collaboration/inventorship/ownership | FTOs | Cost pressures | Funding | IP Strategy | Commercialisation strategy | Plausibility and Sufficiency | Multidisciplinary teams | Priority | Trade marks and other commercial considerations
Read more Partners and patent attorneys Ean Davies and Adam Tindall discuss: Reimagining the in-house team/outside counsel relationship | Getting the best from private practice IP attorneys | IP during a recession
Read more
We live in an increasingly digital world – not only do more of us communicate with each other and access information or content using ‘apps’ and the internet, but some of the work we may have previously conducted in the ‘real’ or physical world is now being performed using computer simulations or digital twins.
Read more What is CRISPR? Clustered regularly interspaced short palindromic repeats (CRISPRs) are a family of DNA sequences found in bacteria.
Read more
Lab-based scientists may not be able to access their workspace during lockdown, but there are things that can be done remotely to further an IP programme. In part three of our series, “Progressing innovation outside the lab”, we outline strategic tasks that physics and engineering-focused researchers and scientists can complete to further intellectual property during time away from the lab.
Read more
This three-part series examines how intellectual property protection can continue in a productive and effective way, during this time of remote working, shifting priorities, uncertainty and change.
Read more
IP Solicitor Chris Thomas highlights the need for brand owners and manufacturers to protect trade secrets in the food and beverage industry.
Read more
Julia Gwilt and Parminder Lally attended the Cambridge Wireless event on "Narrowing the Intelligence Gap", hosted at Amazon's site in Cambridge. The event featured an excellent talk by Neil Lawrence (IPC Machine Learning at Amazon and Professor of Machine Learning at the University of Sheffield) on whether the latest AI is "more human".
Read more
After years of controversy, the Technical Board of Appeal (TBA) of the EPO has recently decided that products obtained by essentially biological processes can be patent protected (T1063/18).
Read more
What’s the problem with ‘functional limitations’?
Read more
Language, be it written or spoken, can be vague, ambiguous and difficult to interpret.
Read more
